CGT Industrial Upgrade Tour Series - Stop 7: Guangzhou International Enterprise Incubator

Mar 15, 2024 15:06 CST Updated 15:06

Yeasen

Tool Enzyme Raw Materials and Diagnostic Product R&D, Manufacturer

VectorBuilder

Gene Delivery Technology Developer

Life Biosciences

Experimental Animal Research Service Provider

Legend Capital

Early-stage venture capital and growth-stage private equity investment institutions

广州主K.jpg

Event Information

■ Stop 7: Guangzhou Science CityInternational Business Incubator

Event Time: March 21, 2024 (Thursday) 13:30

Event Venue: Conference Room 1, 3rd Floor, Block C, International Business Incubator, No. 3 Juquan Road, Science City, Huangpu District, Guangzhou City, Guangdong Province

Organizer: Healthcare Innovative Ecosystem Alliance (HIEA)

Co-organized by: Xingcheng Biotechnology, Yeasen, LePure Introduction, Austar Group (Hong Kong), VectorBuilder, Shenyan Biotechnology, Life Biosciences,Legend Capital

Organizer: VB New Medicine

Supporting Organizations: Guangzhou International Enterprise Incubator

Since November 2023, VCBeat New Medicine has jointlyCGTSupply chain enterprises, located respectively at the Shanghai Zhangjiang ATLATL Feibiao Innovation Center, Shanghai Free Trade Zone No. 1, Nanjing Bio-Medicine Valley, and SuzhouBioBAY, Beijing Newborn Nest Innovation Center and Beijing Yichuang High-Tech Innovation Science Park hosted six events in the "CGT Industry Upgrade Park Tour" series. During these events, the organizers gathered decision-making elites from numerous CGT innovative enterprises and service providers across the industrial chain to build a platform for open dialogue and authentic exchange. The initiative aimed to deepen communication and cooperation among all parties, jointly create high-quality CGT products, and promote the coordinated development of the entire industrial chain.

As the capital winter persists, strengthening CMC capabilities, exploring financing opportunities, pursuing international expansion, and maintaining survival resilience have become core strategic issues that innovative pharmaceutical companies urgently need to address.

Based on this, byHosted by the Healthcare Innovative Ecosystem Alliance (HIEA), co-hosted by Xingcheng Biotechnology, Yeasen, LePure Introduction, Austar Group, VectorBuilder, Shenzhen Shenyan Biological Technology Co. LTD, Life Biosciences, and Legend Capital, and organized by VBInsight New Medicine.of“[No Need to Compete, Go Further] CGT Industry Upgrade Series · Park Tour Stop 7” will be held on March 21 (Thursday) at the Guangzhou Science City International Business Incubator.

Highlights

CGT from an Investment Perspective: Leveraging investor insights to explore investment and financing strategies in the CGT sector, distilling new pathways for capital operations by innovative pharmaceutical companies, and helping enterprises seize growth opportunities and navigate challenges.

Optimal Supply Chain Solutions: Listen to Party A's needs, and supply chain enterprises work together to explore the most suitable solution, striving to help innovative companies smoothly, quickly, and cost-effectively transition from IND toBLA。

# Overseas Expansion Strategy: Key Insights: Deeply unlock opportunities in the Southeast Asian market, focusing on drug registration and filing in Islamic regions. This highly practical guide for global expansion offers valuable insights for pharmaceutical companies aspiring to venture overseas.

The “Guangzhou International Business Incubator” event marks the seventh stop in the Park Tour series. This series will continue to be held in other industrial parks to drive the continuous upgrading and development of the CGT industry. We look forward to engaging in discussions and making progress together with our industry peers, helping the CGT sector go further!

Event Agenda

■ 13:30-13:40 Opening Remarks by the Moderator + Introduction to the Ecosystem

Moderator | Event Expectations and Ecosystem Synergy

■ 13：40-14：00

Keynote Speech 1 |Rotating Co-organizer Keynote

■ 14：00-15：10

Panel 1 | How to Partner with CGT Companies to Navigate from IND to BLA: Steadily, Swiftly, and Cost-Effectively?

Introduction to Core Competencies and Service Value

How to Engage Constructively with Clients on a Professional Level and Foster Mutual Support

■ 15：10-16：10

Panel 2 | Discussing Industrial Upgrading: Key CMC Points and Solutions for Gene and Cell Therapy

Not Just General Talk on Regulations

Quality Control Strategies and Specific Service Cases

Party A States Requirements, Party B Proposes Solutions

■ 16:10-16:30 Tea Break

■ 16：30-16：50

Keynote Speech 2 |An Investment Perspective on the Progress and Trends in the CGT Industry

Finance as a Tool: Understanding Capital Market Trends

Industry as the Foundation: Current Status and Outlook of the CGT Sector

■ 16：50-17：10

Keynote Speech 3 |Southeast Asia Market Entry Strategies for Innovative Pharmaceutical Companies

Specific Opportunities in Southeast Asia

Drug Registration and Filing in Islamic Regions

Overseas Expansion Collaboration Cases

■ 17：10-18：10

Panel 3 | How Can CGT Companies Effectively “Raise and Spend Capital” in the New Landscape?

Say Goodbye to Cookie-Cutter Roadshows with Random Conversations

Insights and Perspectives: Helping Businesses Demonstrate Value

“Prepare,” Respect Uncertainty

Innovative One-to-Many Interview-Style Project Pitch

■ 18:30-20:30 Dinner Reception (By Invitation Only)

Event Scale: 50 people/session

Event Partnership:

Ms. Fu 17851017836 (WeChat ID same)

Event Registration:

Capillary 17782369627 (WeChat ID same)

WeChatRegistration Recognition

小助手.jpg